Skip to main content
. 2014 Nov 24;8:1619–1627. doi: 10.2147/PPA.S70712

Table S3.

Questions to evaluate CML patient’s knowledge of the disease and TKI treatment

Question 1. What is CML?
Question 2. What has happened in your body (the cause of CML)?
Question 3. What does the TKI medication do in your body (how does the medication work)?
Question 4. What kind of side effects might the medication cause?
Question 5. (Have you talked with your doctor?) What happens if you skip a dose/stop taking your TKI medication?

Notes: Each question has a value of 1 point. The total score will range from 0–5.

Abbreviations: CML, chronic myeloid leukemia; TKI, tyrosine kinase inhibitor.